Barinthus Biotherapeutics

BRNSNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$24.468 M

$0.60 +6.02%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$66.4M

Loss-making

Shares outstanding

40,848,893

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#384Actinium PharmaceuticalsATNM$25.0M
#385IGC PharmaIGC$24.6M
#386Barinthus BiotherapeuticsBRNS$24.5M
#387LongeveronLGVN$24.2M
#388TherapeuticsMDTXMD$24.0M

Where these numbers come from

Share counts and financials for Barinthus Biotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.